{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:28:46Z","timestamp":1790378926383,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.037","type":"journal-article","created":{"date-parts":[[2010,9,26]],"date-time":"2010-09-26T09:43:53Z","timestamp":1285494233000},"page":"7797-7802","source":"Crossref","is-referenced-by-count":10,"title":["A cost\u2013benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus"],"prefix":"10.1016","volume":"28","author":[{"given":"J.M.","family":"Fischinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wasserscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.037_bib0005","unstructured":"Paul Ehrlich Institut. Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (H\u00e4motherapie) gem\u00e4\u00df \u00a7\u00a7 12 und 18 des Transfusionsgesetzes (TFG) (Novelle 2005). Bundesanzeiger 2005;209:1576457."},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.037_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2807\/esm.10.02.00522-en","article-title":"Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000\u20132002: risk of virus transmission and the impact of nucleic acid amplification testing","volume":"10","author":"Offergeld","year":"2005","journal-title":"Eurosurveillance"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2010.09.037_bib0015","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S1386-6532(06)80006-5","article-title":"Blood screening for HBV DNA","volume":"36","author":"Fang","year":"2006","journal-title":"Journal of Clinical Virology"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2010.09.037_bib0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(06)80001-6","article-title":"Hepatitis B A reveiw of the role of NAT in enhancing blood safety","volume":"36","author":"Lelie","year":"2006","journal-title":"Journal of Clinical Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.037_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000082485","article-title":"Hepatitis-Impfung von Blutspendern: notwendig, machbar, bezahlbar?","volume":"31","author":"Gerlich","year":"2004","journal-title":"Transfusion Medicine and Hemotherapy"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.037_bib0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"issue":"26","key":"10.1016\/j.vaccine.2010.09.037_bib0035","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study","volume":"334","author":"Schreiber","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2010.09.037_bib0040","first-page":"110","article-title":"Hepatitis B vaccination of blood donors \u2013 a cost\u2013benefit analysis","volume":"32","author":"Gesemann","year":"1994","journal-title":"Beitr\u00e4ge zur Infusionstherapie und Transfusionsmedizin"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.037_bib0045","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1537-2995.2008.01718.x","article-title":"Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus","volume":"48","author":"Hourfar","year":"2008","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2010.09.037_bib0050","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1386-6532(06)80005-3","article-title":"Assessing the impact of HBV NAT on window period reduction and residual risk","volume":"36","author":"Kleinman","year":"2006","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.vaccine.2010.09.037_bib0055","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.vaccine.2010.09.037_bib0060","first-page":"A62","article-title":"Deutsche Empfehlungen zur gesundheits\u00f6konomischen Evaluation \u2013 Revidierte Fassung des Hannoveraner Konsensus","volume":"4","author":"Konsensus","year":"1999","journal-title":"Gesundheits\u00f6konomie & Qualit\u00e4tsmanagement"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2010.09.037_bib0065","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0264-410X(00)00410-2","article-title":"Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience","volume":"19","author":"Rendi-Wagner","year":"2001","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2010.09.037_bib0070","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2006.04.016","article-title":"Hepatitis A\/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors","volume":"24","author":"Van der Wielen","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.037_bib0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0264-410X(96)00205-8","article-title":"Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule \u2013 results of a post-marketing surveillance","volume":"15","author":"Clemens","year":"1997","journal-title":"Vaccine"},{"issue":"9226","key":"10.1016\/j.vaccine.2010.09.037_bib0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0140-6736(05)73618-7","article-title":"Boosters for hepatitis B. European Consensus Group on hepatitis B immunity","volume":"356","author":"Banatvala","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.037_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00103-004-0985-2","article-title":"Bericht zur Meldung nach \u00a721 TFG f\u00fcr die Jahre 2001 und 2002","volume":"48","author":"Haschberger","year":"2005","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.037_bib0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0958-7578.2005.00556.x","article-title":"Hepatitis B virus vaccination of blood donors \u2013 what costs may be expected?","volume":"15","author":"Ringwald","year":"2005","journal-title":"Transfusion Medicine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.09.037_bib0095","first-page":"57","article-title":"Over a decade of experience with a yeast recombinant hepatitis B vaccine","volume":"18","author":"Safari","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.09.037_bib0100","series-title":"The principles of practical cost\u2013benefit analysis","author":"Sugden","year":"1978"},{"key":"10.1016\/j.vaccine.2010.09.037_bib0105","series-title":"Clinical decision analysis","author":"Weinstein","year":"1980"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.037_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","article-title":"Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up","volume":"142","author":"McMahon","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.vaccine.2010.09.037_bib0115","first-page":"235","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission am Robert-Koch-Institut","volume":"30","author":"Impfkommission","year":"2006","journal-title":"Epidemiologischen Bulletin"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.037_bib0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00103-008-0612-8","article-title":"Infektionsepidemiologische Daten von Blutspendern 2006","volume":"51","author":"Willand","year":"2008","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T02:48:51Z","timestamp":1559702931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":24,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10013472"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}